Visual and Patient Reported Outcomes of Clareon TruPlus IOL in Cataract Surgery Patients
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This is a prospective, single-site, two-surgeon, single-arm, observational study evaluating the Clareon TruPlus IOL. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the IOLSAT Questionnaire.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Willing and able to understand and sign informed consent.
• Adult patients (\>40 years old) undergoing age-related cataract surgery with expected best-corrected visual outcomes of 20/25 or better in both eyes pre-operatively as determined by surgeon and with regular corneal astigmatism correctable to less than 0.75 diopters post-operatively with no more than a T6 toric power IOL.
• Normal ocular findings aside from cataract and mild dry eye.
Locations
United States
Minnesota
Ovo Lasik + Lens
RECRUITING
Saint Louis Park
Contact Information
Primary
Ashley Prepeluh
ashley.prepeluh@ovoeye.com
952-204-5060
Time Frame
Start Date: 2026-06-02
Estimated Completion Date: 2027-07-11
Participants
Target number of participants: 40
Treatments
Clareon TruPlus
Related Therapeutic Areas
Sponsors
Leads: OVO LASIK + Lens
Collaborators: Sengi